Lord, Abbett & Co
TDOC icon

Lord, Abbett & Co’s Teladoc Health TDOC Stock Holding History

Lord, Abbett & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-47,876
Closed -$8.7M – 706
2021
Q1 		$8.7M Sell
47,876
-2,276
-5% -$528K 0.02% 549
2020
Q4 		$10M Buy
50,152
+23,692
+90% +$4.82M 0.03% 521
2020
Q3 		$5.8M Sell
26,460
-212,801
-89% -$45.1M 0.02% 552
2020
Q2 		$45.7M Sell
239,261
-332,879
-58% -$58.3M 0.16% 207
2020
Q1 		$88.7M Buy
572,140
+190,393
+50% +$22.2M 0.39% 67
2019
Q4 		$32M Buy
381,747
+164,788
+76% +$12.5M 0.11% 296
2019
Q3 		$14.7M Sell
216,959
-115,453
-35% -$7.6M 0.05% 466
2019
Q2 		$22.1M Buy
332,412
+112,728
+51% +$6.57M 0.07% 405
2019
Q1 		$12.2M Sell
219,684
-7,122
-3% -$435K 0.04% 525
2018
Q4 		$11.2M Sell
226,806
-369,060
-62% -$22.6M 0.04% 510
2018
Q3 		$51.5M Buy
595,866
+230,594
+63% +$16.4M 0.14% 235
2018
Q2 		$21.2M Buy
+365,272
New +$17.8M 0.06% 468
2016
Q1 		– Sell
-211,515
Closed -$3.8M – 942
2015
Q4 		$3.8M Buy
211,515
+36,292
+21% +$670K 0.01% 781
2015
Q3 		$3.91M Buy
+175,223
New +$4.73M 0.01% 778

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Lord, Abbett & Co's TDOC Position: Q2 2021 in Review

Lord, Abbett & Co sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 47,876 shares — an estimated $8.7M sold.

Lord, Abbett & Co first reported a position in TDOC in Q3 2015 and held it in 14 quarters. The position peaked at $88.7M in Q1 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • Lord, Abbett & Co reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 47,876 Teladoc Health shares in Q2 2021, an estimated $8.7M.
  • Lord, Abbett & Co first reported a position in Teladoc Health in Q3 2015 and held it in 14 quarters.
  • Lord, Abbett & Co's Teladoc Health position peaked at $88.7M in Q1 2020.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Lord, Abbett & Co's 13F filing for Q2 2021, filed 11 Aug 2021.